微创腹腔镜手术治疗子宫内膜异位症的病例分析

目的 探讨微创腹腔镜手术治疗子宫内膜异位症的应用价值.方法 收集微创腹腔镜手术治疗子宫内膜异位症病例58例,总结其手术方式、适应证及手术经验.结果 58例患者均在腹腔镜下手术,平均手术时间(78.7±50.6)min,平均住院时间(2.08±1.17)d,术中平均出血量(50±23)mL.结论 微创腹腔镜手术治疗子宫内膜异位症是优良的方法.提高不孕患者的妊娠率.     

腹腔镜手术在子宫内膜异位症治疗中的应用

目的:对应用腹腔镜手术方式对患有子宫内膜异位症的患者实施治疗的临床效果进行研究。方法:抽取88例患有子宫内膜异位症的患者,随机分为对照组和治疗组,平均每组44例。采用常规开腹手术方式对对照组患者实施治疗;采用腹腔镜手术方式对治疗组患者实施治疗。结果:治疗组患者子宫内膜异位症病情治疗效果明显优于对照组;手术操作时间、术后下床活动时间、术后住院治疗时间明显短于对照组;围手术期不良反应率明显低于对照组;手术过程中出血量明显少于对照组。结论:应用腹腔镜手术方式对患有子宫内膜异位症的患者实施治疗的临床效果非常明显。     

腹腔镜治疗子宫内膜异位症96例临床分析

目的 探讨腹腔镜在治疗子宫内膜异位症的价值及方法.方法 回顾2002年元月至2005年元月在自贡市第三人民医院腹腔镜治疗子宫内膜异位症96例临床资料.结果 96例均进行腹腔镜探查术,术中分期Ⅰ期7例,Ⅱ期29例,Ⅲ期57例,Ⅳ期2例.术中根据病灶部位大小,粘连程度给予电灶病灶,分离粘连,卵巢巧克力囊肿剥除术,手术时间:40.12±28.45分钟,出血量86.32±70.40ml,术后给予孕三烯酮治疗.讨论子宫内膜异位症应早诊断,早治疗,利用腹腔镜治疗可提高诊断率,治愈率,减少复发率,成为治疗子宫内膜异位症首选方法.     

腹腔镜手术与传统手术治疗子宫内膜异位症的临床效果对比

目的 对比子宫内膜异住症患者经腹腔镜手术治疗与传统手术治疗的疗效,为提高临床疗效提供理论依据.方法 回顾性分析我院自2010-10 ～2012-10间诊治的128例子宫内膜异位症患者临床治疗情况,将所有患者随机分为两组,研究组行腹腔镜手术治疗,对照组行传统手术治疗,统计学对比两组患者治疗效果,以P＜ 0.05为差异有统计学意义.结果 所有患者全部手术成功,研究组患者平均手术时间(76.8±4.5)min,术中出血量平均为(22.4±2.9) mL,术后无复发,妊娠61例(95.3％),痛经消失或缓解98.1％;对照组患者平均手术时间(81.4±4.9)min,术中出血量平均为(34.5±3.7)mL,术后复发4例(9.4％),妊娠53例(82.8％),痛经消失或缓解82.1％,统计学对比P＜0.05,治疗效果有显著性差异.结论 腹腔镜手术治疗子宫内膜异位症手术时间缩短,术中出血量减少,患者术后无复发,治疗安全高效,患者术后恢复较快,对比传统手术治疗方式显著有效,在临床有推广价值.     

腹腔镜手术治疗子宫内膜异位症的临床疗效分析

目的:分析腹腔镜手术治疗子宫内膜异位症的临床疗效.方法:回顾分析284例子宫内膜异位症行腹腔镜手术的临床资料,分析其疗效.结果:284例子宫内膜异位症患者154例通过腹腔镜成功完成手术,均无严重并发症发生.结论:腹腔镜手术治疗子宫内膜异位症安全、有效、利于恢复,特别对合并不孕症的患者可提高其妊娠率.     

腹腔镜治疗子宫内膜异位症的临床效果研究

目的研究腹腔镜治疗子宫内膜异位症的临床治疗效果。方法选取本院子宫内膜异位症患者90例,收治时间为2013年8月至2015年7月期间,并将子宫内膜异位症患者随机分为两组(观察组和对照组),每组各有45例患者,对照组患者采用开腹手术治疗,观察组患者采用腹腔镜治疗。结果观察组子宫内膜异位症患者治疗后的住院时间、术后下床时间、术后排气时间、术中出血量、手术时间显著优于对照组子宫内膜异位症患者(P0.05)。结论腹腔镜治疗子宫内膜异位症具有良好的临床效果。     

腹腔镜治疗子宫内膜异位症合并不孕的疗效观察

目的观察腹腔镜治疗子宫内膜异位症合并不孕的临床疗效。方法以2012年10月至2014年6月延津县人民医院收治的85例子宫内膜异位症合并不孕患者为研究对象,根据手术方法的不同分为对照组和观察组,其中40例采用开腹手术治疗的患者设为对照组,45例采用腹腔镜手术治疗的患者设为观察组。比较两组的术中出血量、住院时间、术后并发症发生情况、术后1 a的妊娠情况。结果观察组的平均术中出血量少于对照组,平均住院时间短于对照组,术后并发症发生率低于对照组,术后1 a的妊娠率高于对照组,差异均有统计学意义(P<0.05)。结论腹腔镜治疗子宫内膜异位症合并不孕安全有效,患者恢复快,术后妊娠率较高。     

应用等离子刀在腹腔镜下治疗子宫内膜异位症165例

目的:探讨等离子刀在腹腔镜下治疗子宫内膜异位症(内异症)的安全性和有效性。方法:应用等离子刀在腹腔镜下治疗子宫内膜异位症165例,手术分保留生育功能、保留卵巢功能、根治性手术3种方法。结果:手术成功162例,中转开腹3例。结论:应用等离子刀在腹腔镜下治疗子宫内膜异位症具有损伤小、出血少、恢复快、住院时间短、术后生活质量高等优点。等离子刀1次完成分离、止血、切割,使手术变得简单易行,是治疗子宫内膜异位症安全、有效、理想的手术方式。     

电视腹腔镜治疗子宫内膜异位症178例疗效观察

目的 探讨电视腹腔镜治疗子宫内膜异位症的疗效.方法 回顾性分析178例子宫内膜异位症患者采用电视腹腔镜治疗后的效果.结果 本组178例中,镜下手术成功166例,成功率93.3%,术后患者痛经和性交痛症状均有明显缓解.结论 电视腹腔镜是治疗子宫内膜异位症的一种较安全、有效的方法.     

腹腔镜下治疗子宫内膜异位症68例

目的 探讨腹腔镜手术治疗子宫内膜异位症的临床价值.方法 回顾性分析腹腔镜下手术治疗68例子宫内膜异位症患者(研究组)的临床资料,并选择50例行开腹手术治疗子宫内膜异位症患者(对照组)进行对照分析.结果 两组手术时间比较差异无统计学意义(P>0.05);研究组术中出血量少,术后离床活动时间短,恢复快,肛门排气时间早,术后住院日短,术后妊娠率高,与对照组比较,差异具有统计学意义(P<0.05).腹腔镜术后,患者术前症状缓解率高,术后复发率低,与开腹术比较,差异无统计学意义(P>0.05).结论 腹腔镜手术治疗子宫内膜异位症安全、有效、恢复快,尤其对合并不孕症的患者,既可明确诊断,又可同时治疗,提高妊娠率.     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine

Evidence obtained from randomized controlled trials （RCTs） has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine （TCM） and results have shown that there is an urgent need for higher quality RCTs on TCM.     

TCM Treatment of Ankylosing Spondylitis by Tonifying the Kidney and Strengthening the Governor Vessel

Ankylosing spondylitis is a chronic and progressive disorder with inflammation mainly involving the central axis joints. It mainly affects the cervical spine and the lumbosacral area, with the pathogenesis closely related to the kidney and the Governor Vessel (GV). TCM holds that the syndrome is deficiency in origin and excess in superficiality, which is due to insufficiency of the kidney, deficiency of GV, and blocking of the channels with the invasion of exogenous evil, leading to poor circulation of qi and blood and malnutrition of the bones, muscles and joints. The TCM method of tonifying the kidney and strengthening GV to regulate circulation of qi and blood and check the arthralgia pain should be adopted, with the Kidney-Tonifying and GV Strengthening Decoction (益肾强督汤) prescribed.     

IMPROVING P-gp EXPRESSION IN HUMAN MONONUCLEAR CELLS IN VITRO TRANSFECTED BY MULTIDRUG RESISTANCE-1 mRNA

CHEMOTHERAPY playsa greatrolein the treat- ment of malignanttumors,especiallyingynecolo- gicalones.But inanticancerchemotherapy,leuko-cytopeniaisfrequentlytheprimarydose-limitingsideeffect factor.Moreover,cancersarefrequentlychemoresistantbe-causeof overexpressionof P-glycoprotein(P-gp), which isencodedby multidrugresistancegene (MDR1 ) and detectableinup to50% ofhuman cancersand renderscellsresistancetoanticancerdrugs.The safetyand potentialtherapeuticbenefitof mdr1 gene transferredto h…